These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7481574)

  • 1. The epidemiology of drug-induced akathisia: Part I. Acute akathisia.
    Sachdev P
    Schizophr Bull; 1995; 21(3):431-49. PubMed ID: 7481574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.
    Sachdev P
    Schizophr Bull; 1995; 21(3):451-61. PubMed ID: 7481575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.
    Hansen L; Jones RM; Kingdon D
    J Psychopharmacol; 2004 Sep; 18(3):384-7. PubMed ID: 15358982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
    van Harten PN; Matroos GE; Hoek HW; Kahn RS
    Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    Kumsa A; Agenagnew L; Alemu B; Girma S
    PLoS One; 2020; 15(7):e0235365. PubMed ID: 32614868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study.
    Horiguchi J; Nishimatsu O
    Jpn J Psychiatry Neurol; 1992 Sep; 46(3):733-9. PubMed ID: 1362592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia.
    Sundram S; Lambert T; Piskulic D
    Acta Psychiatr Scand; 2008 Jun; 117(6):474-8. PubMed ID: 18479320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the relationship of atypical and low-dose conventional antipsychotics with akathisia in a clinical patient population.
    Markkula J; Helenius H; Lauerma H
    Nord J Psychiatry; 2007; 61(2):152-7. PubMed ID: 17454730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproheptadine treatment in neuroleptic-induced akathisia.
    Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
    Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
    Yoshimura B; Sato K; Sakamoto S; Tsukahara M; Yoshimura Y; So R
    Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and predisposing factors in acute drug-induced akathisia.
    Sachdev P; Kruk J
    Arch Gen Psychiatry; 1994 Dec; 51(12):963-74. PubMed ID: 7979885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
    Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characteristics of subjective akathisia, objective akathisia, and mixed akathisia in chronic schizophrenic subjects.
    Kim JH; Byun HJ
    Clin Neuropharmacol; 2003; 26(6):312-6. PubMed ID: 14646611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handedness as a risk factor for neuroleptic-induced movement disorders.
    Brown KW; White T; Anderson F; McGilp R
    Biol Psychiatry; 1992 Apr; 31(7):746-8. PubMed ID: 1350923
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for the development of neuroleptic induced akathisia.
    Miller CH; Hummer M; Oberbauer H; Kurzthaler I; DeCol C; Fleischhacker WW
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):51-5. PubMed ID: 9088885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism.
    Sandyk R; Kay SR
    Ital J Neurol Sci; 1990 Oct; 11(5):439-42. PubMed ID: 1980270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
    Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.